Literature DB >> 3811968

Phenobarbital enhances the aldehyde dehydrogenase activity of rat hepatocytes in vitro and in vivo.

M Marselos, G Michalopoulos.   

Abstract

Aldehyde dehydrogenase (ALDH) was measured in primary cultures of hepatocytes obtained with collagenase perfusion from livers of Long-Evans rats. After seven days in culture, basal ALDH activity, protein content and DNA content are significantly decreased. Exposure of the cultures to phenobarbital (PB, 3 mM in the media) does not prevent the decrease of DNA content, although it keeps protein at relatively higher levels. The activity of ALDH is not only preserved, but also significantly enhanced, when propionaldehyde, phenylacetaldehyde, benzaldehyde and D-glucuronolactone are used as substrates and NAD as the coenzyme. A relative increase of activity is also noted when ALDH is measured with benzaldehyde and NADP. Treatment of Long-Evans animals with PB (1 mg/ml, in drinking water for 2 weeks) leads to similar relative increases of the ALDH activity. In absolute values, however, enzyme activities found after in vivo treatment with PB are higher, compared to those obtained after in vitro exposure. These results show that ALDH activity can be greatly enhanced by PB in primary hepatocyte cultures, free from any indirect endogenous influences.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3811968     DOI: 10.1111/j.1600-0773.1986.tb00191.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  3 in total

1.  Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats.

Authors:  H Foth; H Looschen; H Neurath; G F Kahl
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Changes in the inducibility of a hepatic aldehyde dehydrogenase by various effectors.

Authors:  V Vasiliou; M Marselos
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Zoxazolamine-induced paralysis in two rat substrains: differences in hepatic drug metabolism.

Authors:  P Pappas; P Stephanou; V Vasiliou; M Marselos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.